cerrar
Tagged with Free

Interview: Zsolt Jozsa – General Manager, Novo Nordisk…
Novo Nordisk Hungary GM Zsolt Jozsa highlights the growing prevalence of diabetes in Hungary, the gap in treatment options that the company is…

Interview: Tsuyoshi Hasuo – President & CEO; Bertrand…
Thépenier CEO Tsuyoshi Hasuo has imparted a unique vision to internationalize the Normandy-based French company encompassing a company turnaround and…

Mambo Italiano: Local Pharma’s Fragmentation Conundrum
Long renowned for dancing to a different tune, Italy’s eccentric, but more often than not, enlightened and high performance pharma, healthcare and…

Interview: Eric Ducournau – CEO, Pierre Fabre…
Eric Ducournau, CEO of Pierre Fabre Dermo-Cosmétique (PFDC), discusses the company’s revolutionary lines of dermatologically tested skincare…

Interview: Giuseppe Cassisi – CEO, Doppel, Italy
Doppel has been selected as the nucleus for significant investments in the CDMO industry by PE firm Trilantic Capital Partners, according to…

Interview: Martin Minarovič – Managing Director, Janssen…
Janssen Czech Republic’s MD reviews his longstanding career within the company and highlights how founder Dr. Paul Janssen’s legacy still…

Interview: Sergio Liberatore – CEO, IMS Health Italy
Sergio Liberatore discusses IMS Health Italy's evolution after the acquisition of Cegedim’s CRM and strategic data businesses and how IMS is…

Egypt’s Campaign against Viral Hepatitis
As Egypt continues to grapple with the proliferation of the hepatitis C virus, fresh treatment, prevention and market access pathways are now being…

Egyptian Regulatory Reform: “Taming the Beast”
Concerted efforts are, at last, being made to redraw the rulebook and tidy up a local regulatory landscape long renowned for its torpor, dysfunction…

Interview: Abramo Brandi – Managing Director, Octapharma…
Abramo Brandi, Octapharma Italy’s MD, discusses the challenges of the tender system in Italy and how he has grown the company year-on-year in the…

Interview: Mario Marazziti – President of the XII Social…
Mario Marazziti, President of the Italian XII Social Affairs Commission, discusses new legislation relating to clinical risk, the effects of the 2014…

Interview: Luigi Boggio – President, Assobiomedica;…
Luigi Boggio, President of Assobiomedica, the association representing the medtech industry, and MD of B. Braun Italy, calls on the Italian government…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here